Biotech Investments Surge as Clinical Trials Market Expands
The biotech sector has seen a significant influx of investments, with Abingworth, a life sciences investment group, raising $356 million for late-stage pharma and biotech clinical programs. This fund will support the development of innovative therapeutics in the US, UK, Europe, and Asia-Pacific. Abingworth's success in clinical co-development since 2009 has led to partnerships with major companies like AstraZeneca and Pfizer, and it has invested in over 185 life sciences companies over the last 50 years.
This investment trend is mirrored in the clinical trials market, which is expected to grow from $48.2 billion in 2023 to $73.2 billion by 2028, at a CAGR of 8.7%. The market is driven by an increasing number of clinical trials, a growing pipeline of drugs, and rising investment in pharmaceutical R&D. However, the market faces challenges such as the need for unique testing approaches for innovative molecules and a shortage of skilled professionals.
For businesses and industries utilizing AI models, these developments are significant. AI can streamline the clinical trial process, enhance drug discovery, and improve the efficiency of R&D investments. As the market grows, there will be a greater demand for AI-driven solutions in clinical trials, offering opportunities for businesses to innovate and provide advanced analytics, patient recruitment, and data management services.
The synergy between biotech investments and the clinical trials market underscores the importance of strategic partnerships and the integration of AI to accelerate the development of new therapies. Companies that leverage these trends can expect to gain a competitive edge in the rapidly evolving landscape of pharmaceutical and biotech R&D.
GET AHEAD
Top Research Reports to Fuel Your Industry KnowledgeEditor's Pick
Information and Communication Technology
Insurtech Funding News - Coverdash raises USD 13.5 MillionPODCASTS
Sustainable Digital Transformation & Industry 4.0
Sanjay Kaul, President-Asia Pacific & Japan, Cisco, and host Aashish Mehra, Chief Research Officer, MarketsandMarkets, in conversation on unraveling 'Sustainable Digital Transformation and Industry 4.0'
11 July 2023|S2E12|Listen Now
Generative AI
Prasad Joshi, Senior Vice President-Emerging Technology Solutions, Infosys, and host, Vinod Chikkareddy, CCO, MarketsandMarkets, in exploring the recent advances in AI and the generative AI space.
7 Nov 2023|S2E13|Listen Now
Clinical Trials Market
Download Whitepaper